What Is DPG in Blood and How Does It Affect Oxygen?

DPG, short for 2,3-diphosphoglycerate (also called 2,3-BPG or 2,3-bisphosphoglycerate), is a small molecule found almost exclusively inside red blood cells, where it acts as a chemical switch controlling how tightly hemoglobin holds onto oxygen. When DPG levels rise, hemoglobin releases oxygen more readily into surrounding tissues; when they fall, hemoglobin grips oxygen more tightly and is less willing to let go. This simple regulatory lever turns out to have wide-reaching consequences, from how your body copes at high altitude to why stored blood for transfusions does not work as well as fresh blood.

Where DPG Comes From

Red blood cells make DPG as a byproduct of glucose metabolism through a side route called the Rapoport-Luebering shunt. Normally, glucose gets broken down in a series of steps that generate energy. But at one specific step, an enzyme diverts an intermediate molecule sideways, converting it into 2,3-DPG instead of sending it straight down the main energy-producing pathway. A second enzyme then breaks DPG back down, feeding its product back into the main pathway. This constant creation and destruction of DPG keeps its concentration in a controlled range within each red blood cell.¹

What makes this side pathway so important is that red blood cells have no nuclei and no mitochondria, so glycolysis is their only source of energy. By siphoning off an intermediate to make DPG, the cell sacrifices a bit of energy production in exchange for a powerful tool to regulate oxygen delivery. The body can adjust the rate of that diversion depending on what tissues need.²

How DPG Changes Oxygen Delivery

Hemoglobin is the protein in red blood cells that picks up oxygen in the lungs and carries it to every corner of the body. It can exist in two shapes: a “relaxed” form that loves oxygen and a “tense” form that releases it. DPG wedges itself into the central cavity of hemoglobin’s tense form, physically stabilizing that shape and making the molecule less eager to hang onto oxygen. The result is that hemoglobin unloads more oxygen at any given tissue oxygen level.³

Physiologists track this effect using a value called P50, which is the oxygen pressure at which hemoglobin is exactly half-saturated. A higher P50 means hemoglobin releases oxygen more easily. When DPG levels go up, the entire oxygen-hemoglobin curve shifts to the right, pushing P50 higher and enhancing oxygen delivery to tissues. This is especially valuable in conditions where the body is under stress, such as anemia or acclimatization to thin mountain air.⁴

DPG is not the only factor that shifts the curve. Acidity (lower pH), higher carbon dioxide, and higher temperature all push hemoglobin to release oxygen, a cluster of effects collectively called the Bohr effect. But DPG operates on a different timescale. While pH and CO2 respond breath-by-breath, DPG levels adjust over hours to days, making it better suited to chronic conditions like prolonged altitude exposure or persistent anemia rather than moment-to-moment changes.

Sex Differences in DPG

An underappreciated finding is that women tend to have higher DPG concentrations in their red blood cells than men. A study that controlled for carbon dioxide, temperature, and pH between groups found significantly elevated 2,3-BPG in women regardless of fitness level. Those higher DPG levels correlated strongly with higher P50 values, meaning the women’s hemoglobin released oxygen at higher pressures.⁵

The reason is likely a compensatory mechanism. Women generally carry lower hemoglobin concentrations than men, so each red blood cell needs to be slightly more efficient at offloading oxygen to make up the difference. Higher DPG is one way the body achieves that. This is a good example of DPG working in the background: a person with lower hemoglobin does not necessarily feel short of breath, partly because DPG has already recalibrated the system.

DPG at High Altitude

When you travel to high altitude, the air contains less oxygen per breath. Within the first day or two, red blood cells start ramping up DPG production. Early research on populations living at elevation found that DPG levels were significantly higher in both men and women compared to people at sea level, and this increase was likely responsible for the well-documented rightward shift of the oxygen dissociation curve seen in altitude residents.⁶

The logic is straightforward. With less oxygen available in the lungs, hemoglobin arrives in tissues still relatively saturated. By increasing DPG, the body essentially loosens hemoglobin’s grip so that more oxygen gets squeezed out at the tissue level. This adjustment kicks in faster than other altitude adaptations like building more red blood cells, which takes weeks. DPG rises within hours and stabilizes over days, making it one of the body’s earliest acclimatization tools.

How Exercise Affects DPG

Hard physical effort triggers a noticeable bump in red blood cell DPG, though the rise is not instantaneous. After heavy exercise, DPG remains flat or dips slightly in the first few minutes, then climbs to a new plateau roughly 30 to 45 minutes afterward. In one set of experiments, six minutes of intense work raised DPG about 8% above baseline, while a longer double bout produced a stepwise increase of about 12%. A 60-minute bout settled at roughly 10% above resting levels. In all cases, the elevated DPG persisted for at least four hours afterward.⁷

Training over months has a cumulative effect. A study of military recruits found that six months of physical training produced a roughly 10% increase in resting DPG alongside a 16% improvement in predicted maximal oxygen uptake. Recruits who started with lower fitness saw the biggest DPG gains. Interestingly, very competitive anaerobic efforts that generate a lot of lactic acid did not raise DPG the same way, probably because lactate and the accompanying acidosis suppress the Rapoport-Luebering shunt. Researchers even proposed that DPG response to a standard exercise bout could serve as a marker for how well someone is adapting to training.⁸

Why Fetal Blood Works Differently

A developing fetus faces a unique oxygen challenge: it cannot breathe, so it must extract oxygen from the mother’s blood across the placenta. The solution involves fetal hemoglobin (Hb F), which has a different structure from adult hemoglobin (Hb A). Fetal hemoglobin binds DPG much more weakly than adult hemoglobin does. Because DPG is what normally loosens hemoglobin’s grip on oxygen, having less DPG interaction means fetal hemoglobin holds onto oxygen much more tightly.⁹

The practical outcome is elegant. In the placenta, maternal red blood cells (loaded with adult hemoglobin and plenty of DPG) release oxygen easily because their DPG is actively loosening the grip. Fetal red blood cells, sitting right next to them, grab that oxygen aggressively because their hemoglobin is not being told to let go. Oxygen flows downhill from low affinity to high affinity, from mother to baby, without any active pumping required.

On the production side, adult deoxyhemoglobin actually stimulates DPG synthesis by binding the DPG that is produced and preventing it from inhibiting its own creation. Fetal deoxyhemoglobin does not do this, which further contributes to the difference in how DPG operates in the two systems.¹⁰

The Stored Blood Problem

When blood is collected and stored in a blood bank, the red blood cells gradually lose their DPG. The decline is dramatic. Stored red blood cells lose about 90% of their DPG, and their P50 drops by roughly 30% compared to fresh red cells.¹¹ Most of this loss happens within the first three weeks, at which point DPG levels are nearly undetectable.¹²

This means that stored blood, while still capable of carrying oxygen, holds onto it too tightly. Transfused red cells may reach the tissues but not offload their oxygen efficiently until the body has had time to regenerate DPG within them, a process that takes roughly 24 to 48 hours after transfusion. For a patient receiving a massive transfusion during surgery or trauma, that delay could matter.

Researchers have worked on this problem for decades. One approach uses a rejuvenation solution containing pyruvate, inosine, glucose, phosphate, and adenine, which can restore DPG in stored cells to about 1.5 times normal levels. In clinical use, these rejuvenated cells showed decreased oxygen affinity and were able to deliver oxygen at high tension immediately after rapid infusion.¹³ Despite encouraging results, rejuvenation has not become routine in most blood banks, partly because of cost and logistical complexity. The clinical significance of DPG depletion in typical transfusion scenarios continues to be debated, since most patients receiving a few units can regenerate their DPG within a day or two.

DPG in Disease

Several diseases alter DPG levels in ways that either help or hurt patients.

Pyruvate Kinase Deficiency

Pyruvate kinase deficiency is a genetic condition that disrupts the normal energy-producing machinery in red blood cells, causing chronic hemolytic anemia: the cells break apart faster than normal. But the metabolic blockage also causes a buildup of pathway intermediates upstream of the defective enzyme, and one of the most prominent is DPG. This elevated DPG means that even though patients have fewer red blood cells, the ones they have unload oxygen more efficiently. Some patients with pyruvate kinase deficiency tolerate strikingly low hemoglobin levels with fewer symptoms than you would expect, and elevated DPG is a key reason why.¹⁴

Diabetic Ketoacidosis

In diabetic ketoacidosis (DKA), the picture is the opposite: DPG levels fall. Patients admitted with DKA have low red blood cell DPG at the start of treatment, and levels stay low throughout the first 24 hours. Low DPG means hemoglobin is clinging to oxygen when it should be releasing it, which could worsen tissue oxygen delivery on top of the acidosis, dehydration, and metabolic chaos already happening. The phosphate depletion that accompanies DKA is likely the main driver, since phosphate is a required substrate for DPG synthesis. This is one of the reasons clinicians consider phosphate replacement during early DKA treatment.¹⁵

Sickle Cell Disease

In sickle cell disease, DPG plays a more complicated role. By loosening hemoglobin’s grip on oxygen, DPG promotes the deoxygenated state of hemoglobin S, which is the very state that triggers sickling. Higher DPG also acidifies the cell interior, further lowering the solubility of deoxygenated hemoglobin S. So while DPG normally helps healthy red blood cells deliver oxygen, in sickle cells it inadvertently promotes the destructive polymerization that deforms the cells. Laboratory experiments using a compound that rapidly depletes intracellular DPG reduced the polymer fraction in sickle red cells by roughly a third to nearly two thirds, with sickling decreasing by about half to as much as 95% at oxygen pressures typical of small blood vessels.¹⁶ This avenue of research has remained mostly experimental, but it highlights how the same molecule can be friend or foe depending on the hemoglobin variant present.

Not All Mammals Rely on DPG

Humans are far from the only species that use DPG to regulate oxygen delivery. Dogs, horses, rabbits, guinea pigs, and rats all have hemoglobins that are strongly influenced by DPG. Stripped of organic phosphates, these hemoglobins all bind oxygen extremely tightly, and DPG is what brings their oxygen affinity down to a functional range.¹⁷

But other mammals have taken a completely different evolutionary path. Cats, cattle, sheep, and goats all have hemoglobins that naturally sit at a low oxygen affinity without needing DPG to adjust them. Their red blood cells contain very little DPG, and their hemoglobin reacts only weakly to whatever DPG is present. These two groups are not closely related to each other: the cat family (Feloidea) and the cattle-sheep-goat group (Bovoidea) evolved this trait independently.¹⁸ Their hemoglobins have built-in structural features that accomplish what DPG does in humans, making the molecule essentially redundant in those species. This is a reminder that DPG is not some universal law of blood physiology, but rather one of several evolutionary strategies for tuning oxygen delivery.

Pharmaceutical Research on DPG Mimics

Knowing how powerfully DPG can shift oxygen delivery, researchers have tried to develop drugs that mimic its effects. The idea is to create molecules that bind hemoglobin in the same central cavity, stabilize the tense form, and push P50 higher, essentially accomplishing what natural DPG does but in a controlled, pharmaceutical way. In one line of research, synthetic phosphate-based compounds tested in animal models simulating extreme altitude increased hemoglobin’s P50 by up to about 35%, a substantial shift that improved tissue oxygenation under severely hypoxic conditions.¹⁹

The potential applications range from treating altitude sickness and improving stored blood for transfusions to managing tissue hypoxia in critically ill patients. Some compounds in this space, like voxelotor (approved for sickle cell disease), work in the opposite direction: they increase hemoglobin’s oxygen affinity to prevent sickling, essentially mimicking what happens when DPG is removed. The field of hemoglobin allosteric modulators is a direct outgrowth of decades of research into how DPG works, and it underscores just how central this small molecule is to our understanding of blood oxygen physiology.